There is a lot of interest in the development of a biomarker for autism that could predict autism risk, assist in diagnosis, or even provide targets for possible treatment options. This presentation will walk you through the status of current biomarker research, providing realistic assessments of how biomarkers could be used clinically, and will address some of the ethical and social implications.
Presented by Dr. Laura Hewitson, Director of Research at The Johnson Center
